Drug Profile
JNJ 3534
Alternative Names: JNJ-3534; RORγt inhibitor - Janssen/Phenex PharmaceuticalsLatest Information Update: 28 Aug 2020
Price :
$50
*
At a glance
- Originator Phenex Pharmaceuticals
- Developer Janssen
- Class Antipsoriatics; Small molecules
- Mechanism of Action Nuclear receptor subfamily 1 group F member 3 antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Psoriasis